TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

127.60$ +2.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement INCY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
0.6% 3.6% 5.3% 5.2% 5.0% 5.3% 4.9% 5.1% 6.1% 6.9% 7.4% 7.2%
99.4% 96.4% 94.7% 94.8% 95.0% 94.7% 95.1% 94.9% 93.9% 93.1% 92.6% 92.8%
67.9% 63.6% 52.6% 86.3% 63.7% 53.5% 83.1% 48.8% 46.7% 44.0% 61.5% 39.9%
32.4% 26.1% 27.4% 23.9% 22.5% 21.7% 19.4% 24.8% 29.5% 31.4% 28.8% 26.8%
100.4% 89.7% 81.6% 110.7% 88.1% 76.1% 105.0% 75.3% 76.5% 75.4% 90.3% 66.6%
-0.9% 6.7% 13.1% -15.8% 6.9% 18.6% -9.9% 19.6% 17.4% 17.7% 2.4% 26.1%
9.2% 6.1% 3.5% 0.4% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0%
-9.5% 1.0% 9.7% -20.3% 6.1% 22.5% -8.7% 19.1% 15.6% 22.6% 7.5% 32.4%
0.0% 0.1% 0.3% 0.1% 0.3% 1.8% 2.4% -12.7% 5.6% 6.4% 6.7% 7.3%
-9.5% 0.9% 9.4% -20.4% 5.8% 20.7% -11.1% 31.8% 10.0% 16.2% 0.8% 25.0%
7.8% 13.0% 18.5% -16.5% 9.1% 25.2% -6.7% 21.1% 17.7% 24.9% 9.6% 34.2%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?